About
Risedronate 35mg, a potent bisphosphonate, is a cornerstone medication in the management and prevention of osteoporosis, particularly in postmenopausal women and men. Its primary mechanism of action involves inhibiting the activity of osteoclasts, the specialized cells responsible for bone resorption and breakdown. By binding to the bone mineral surface, risedronate effectively slows down the rate of bone turnover, thereby preserving existing bone mass and promoting an increase in bone mineral density. This crucial action significantly reduces the risk of fragility fractures, including those of the spine and hip, which are common and debilitating complications of osteoporosis. The convenient once-weekly dosing regimen of 35mg enhances patient adherence, making it a practical and effective long-term treatment option for improving skeletal health and reducing fracture incidence.
Uses
- Treatment of postmenopausal osteoporosis.
- Prevention of osteoporosis in postmenopausal women.
- Treatment of osteoporosis in men.
- Treatment and prevention of glucocorticoid-induced osteoporosis.
Directions For Use
Take one tablet orally once a week, preferably on the same day each week, at least 30 minutes before the first food, drink (other than plain water), or other medication of the day. Swallow whole with a full glass of plain water while sitting or standing upright.
Benefits
- Significantly reduces fracture risk.
- Increases bone mineral density.
- Convenient once-weekly dosing.
- Improves bone strength.
- Effective in postmenopausal and male osteoporosis.
- Helps prevent bone loss.
Side Effects
- Esophageal irritation or ulceration.
- Dyspepsia.
- Abdominal pain.
- Nausea.
- Diarrhea.
- Constipation.
- Musculoskeletal pain.
- Headache.
- Dizziness.
- Rash.
- Jaw osteonecrosis (rare).
- Atypical femoral fractures (rare).
Safety Measures
- Alcohol - Excessive alcohol intake can increase the risk of osteoporosis and may interfere with bone healing. It is advisable to limit alcohol consumption while on this medication.
- Pregnancy - This medication is generally not recommended during pregnancy due to potential fetal harm. Consult a doctor if pregnant or planning pregnancy.
- Breastfeeding - It is unknown if risedronate is excreted in human milk. A decision should be made whether to discontinue nursing or the drug, considering the importance of the drug to the mother.
- Liver - No dose adjustment is typically required for patients with mild to moderate liver impairment. Use with caution in severe liver disease.
- Kidney - Not recommended for patients with severe renal impairment (creatinine clearance < 30 mL/min). Dose adjustment may be needed for moderate impairment.
- Lung - No specific precautions regarding lung conditions are generally noted for this medication.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!